Is There A Link Between Pancreatic Cancer And Diabetes After Age 50? Pancreatic Cancer Action Network Launches $25 Million, Large-Scale Study prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Budget Passed By Congress Includes Increase In Federal Funding For Cancer Research
Advocates From Pancreatic Cancer Action Network Were Instrumental in Securing Bipartisan Support For Pancreatic Cancer Research at Department of Defense
News provided by
Share this article
Share this article
LOS ANGELES, Dec. 22, 2020 /PRNewswire/ Congress delivered a key victory for pancreatic cancer patients and researchers today by passing its Fiscal Year (FY) 2021 budget. In response to the advocacy efforts of the Pancreatic Cancer Action Network (PanCAN), the spending package includes $15 million for the Department of Defense s (DoD) dedicated Pancreatic Cancer Research Program, more than doubling last year s inaugural investment. In addition, the package includes an overall increase in the nation s investment in biomedical research funding of $42.9 billion to the National Institutes of Health (NIH) and $6.56 billion to the National Cancer Institute (NCI).
to PanCAN.
Anne-Marie is a senior executive with extensive experience in the biopharmaceutical industry. In her most recent role as executive vice president and chief medical officer at Rigel Pharmaceuticals, she led the development of new drugs for auto-immune diseases and was responsible for getting their first drug approved.
Anne-Marie has lost several friends to pancreatic cancer and another is currently battling the disease. She looks forward to bringing her expertise to large-scale, life-changing initiatives like PanCAN’s Precision Promise℠ to improve treatment options for pancreatic cancer patients.
Here, we share more about Anne-Marie’s background, interests and what brought her to PanCAN.
The Pancreatic Cancer Action Network (PanCAN) Welcomes New Leadership With The Appointment Of A New Board Member And The Hiring Of A Chief Medical Officer
Strategic Leadership Comes as Awareness and Momentum Around Pancreatic Cancer is Increasing Following a Succesful Pancreatic Cancer Awareness Month in November
News provided by
Share this article
LOS ANGELES, Dec. 10, 2020 /PRNewswire/ The
Pancreatic Cancer Action Network (PanCAN), a leading nonprofit in the fight against pancreatic cancer, has appointed Rodney Williams as the newest member of its board of directors (BOD) and hired Anne-Marie Duliege, M.D. as the organization s new chief medical officer (CMO). These leadership updates bring new energy and expertise to the national organization whose bold action is leading the way to accelerate progress for pancreatic cancer patients and create a world in which all pancreatic cancer patients will thrive.